---
title: "CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs"
date: "2025-03-09T10:55:43.000Z"
publishedDate: "9 mars 2025"
summary: "A real-world study of the Prevail (Medtronic) drug-coated balloon (DCB), comparing the device to other contemporary DCBs, has shown similar outcomes with the devices. The data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), were presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 (8–11 March, Washington DC, USA) by Sacharias [&#8230;] The post CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/crt2025-scaar-prevail-dcb/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-03-09-crt-2025-scaar-analysis-shows-comparable-outcomes-between-prevail-and-other-dcbs"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/03/IMG_3311-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/crt2025-scaar-prevail-dcb/"
---

![CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/03/IMG_3311-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/crt2025-scaar-prevail-dcb/*

## L’essentiel

A real-world study of the Prevail (Medtronic) drug-coated balloon (DCB), comparing the device to other contemporary DCBs, has shown similar outcomes with the devices. The data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), were presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 (8–11 March, Washington DC, USA) by Sacharias [&#8230;] The post CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/crt2025-scaar-prevail-dcb/
